Contract A207_PO-0455672

The University of Virginia awarded a contract to Eurofins Genomics LLC on July 8, 2026, for the supply of oligonucleotide primers and molecular biology reagents. The contract, identified as A207_PO-0455672, carries a cumulative value of fifty-four dollars and encompasses twelve line items consisting of salt-free, 25-nucleotide DNA oligonucleotides designated for research applications. All materials are to be delivered to Thurl E Harris at the University of Virginia in Virginia. The individual line items range in unit price from $4.18 to $5.06 per oligonucleotide sequence.

The contract consists of twelve distinct oligonucleotide sequences, including forward and reverse primers for adrenergic receptor genes (Adrb1 and Adrb3) and various oIMR-designated primer sequences. Each line item represents a single unit purchase of a specifically coded DNA sequence in salt-free formulation, suitable for polymerase chain reaction (PCR) and genomic research applications. No contract period of performance or annual value thresholds are specified in the available documentation, indicating this represents a discrete, transaction-based procurement by the University of Virginia.